Bank of America’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-82
Closed -$47 5821
2025
Q4
$47 Buy
82
+12
+17% +$11 ﹤0.01% 6972
2025
Q3
$69 Buy
70
+8
+13% +$7 ﹤0.01% 7935
2025
Q2
$44 Buy
62
+19
+44% +$13 ﹤0.01% 8125
2025
Q1
$34 Buy
43
+1
+2% +$1 ﹤0.01% 8042
2024
Q4
$46 Buy
42
+18
+75% +$17 ﹤0.01% 7878
2024
Q3
$32 Hold
24
﹤0.01% 7894
2024
Q2
$22 Buy
+24
New +$33 ﹤0.01% 7982
2024
Q1
Sell
-11
Closed -$30 7741
2023
Q4
$30 Buy
+11
New +$48 ﹤0.01% 7583
2023
Q1
Sell
-2
Closed -$32 7812
2022
Q4
$32 Buy
+2
New +$41 ﹤0.01% 7885

Other funds holding BFRI

Bank of America's BFRI Position: Q1 2026 in Review

Bank of America sold out of Biofrontera (BFRI) in Q1 2026, closing a stake of 82 shares — an estimated $47 sold.

Bank of America first reported a position in BFRI in Q4 2022 and held it in 9 quarters. The position peaked at $69 in Q3 2025. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2026.

  • Bank of America reported no remaining Biofrontera position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 82 Biofrontera shares in Q1 2026, an estimated $47.
  • Bank of America first reported a position in Biofrontera in Q4 2022 and held it in 9 quarters.
  • Bank of America's Biofrontera position peaked at $69 in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.